Hbv Clinical Trials
Conditions / Hbv
Delta Trials tracks 54 clinical trials for Hbv in its publicly accessible dataset. Among the listed trials, 10 open for participant enrollment and 15 trials have reached completion. This research is carried out at 381 clinical sites around the world. An additional 29 trials have active registrations outside the recruiting and completed categories. Since 2020, 7 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
54
Total Trials
10
Recruiting
15
Completed
29
Other Active
7
Terminated since 2020
381
Study Locations
Browse by location (381 total)
- Guangzhou, China 8 trialsAll trials in Guangzhou, China
- Shanghai, China 8 trialsAll trials in Shanghai, China
- Wuhan, China 7 trialsAll trials in Wuhan, China
- Chengdu, China 6 trialsAll trials in Chengdu, China
- Jinan, China 5 trialsAll trials in Jinan, China
- Nanjing, China 5 trialsAll trials in Nanjing, China
- Beijing, China 5 trialsAll trials in Beijing, China
- Paris, France 5 trialsAll trials in Paris, France
- Paris, France 5 trialsAll trials in Paris, France
- Jinan, China 5 trialsAll trials in Jinan, China
- Seoul, South Korea 4 trialsAll trials in Seoul, South Korea
- Haikou, China 4 trialsAll trials in Haikou, China
- Shijiazhuang, China 4 trialsAll trials in Shijiazhuang, China
- Xi’an, China 4 trialsAll trials in Xi’an, China
- Houston, United States 3 trialsAll trials in Houston, United States
- Shenyang, China 3 trialsAll trials in Shenyang, China
- Taiyuan, China 3 trialsAll trials in Taiyuan, China
- Kunming, China 3 trialsAll trials in Kunming, China
- Hong Kong, Hong Kong 3 trialsAll trials in Hong Kong, Hong Kong
- Lusaka, Zambia 3 trialsAll trials in Lusaka, Zambia